Edition:
United States

Profile: STAAR Surgical Co (STAA.OQ)

STAA.OQ on NASDAQ Stock Exchange Global Market

10.90USD
22 Sep 2017
Change (% chg)

$0.05 (+0.46%)
Prev Close
$10.85
Open
$10.80
Day's High
$10.95
Day's Low
$10.80
Volume
14,903
Avg. Vol
25,277
52-wk High
$12.30
52-wk Low
$7.40

STAAR Surgical Company designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It operates in the ophthalmic surgical market segment. Its principal products are intraocular lenses used in cataract surgery and implantable collamer lenses used in refractive surgery. It makes lenses used across the world in corrective or refractive surgery, and makes lenses for use in surgery that treats cataracts. Its refractive surgery corrects the types of visual disorders that glasses or contact lenses have treated (myopia, hyperopia, astigmatism and presbyopia). Its refractive surgery corrects the types of visual disorders that glasses or contact lenses have treated (myopia, hyperopia, astigmatism and presbyopia). As of December 30, 2016, it sold its products in more than 60 countries, with direct distribution in the United States, Canada, Japan and Spain, and independent distribution in the remainder of the world.

Company Address

STAAR Surgical Co

1911 Walker Ave
MONROVIA   CA   91016
P: +1626.3037902
F: +1626.3032962

Company Web Links